Idiopathic Constipation
📧 Sign up to get email alerts when something new happens for Idiopathic Constipation.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2015-10-20Clinical Trial Update: 26 Week Efficacy and Safety Trial for Patients With Chronic Idiopathic Constipation [Phase 3]
A Phase 3 efficacy and safety trial for chronic idiopathic constipation sponsored by Ferring was terminated, and results were posted in 2015…
-
CLINICAL_TRIALS trial_result · 2015-10-20Clinical Trial Update: Efficacy and Safety Trial of Elobixibat in Patients With Chronic Idiopathic Constipation [Phase 3]
Phase 3 efficacy and safety trial of elobixibat in chronic idiopathic constipation was terminated. Results were posted in October 2015.
-
CLINICAL_TRIALS withdrawal · 2015-06-03Clinical Trial Update: Elobixibat Colonic Motor Function Study [Phase 2]
The Phase 2 trial of elobixibat for chronic idiopathic constipation has been withdrawn.
-
FDA approval · 2015-01-05FDA Approved: LINZESS — Supplemental Application (Allergan, Inc.)
The FDA approved a supplemental application for Linzess (linaclotide) from Allergan, Inc., indicating agency approval of a supplemental NDA …
-
CLINICAL_TRIALS trial_result · 2014-12-19Clinical Trial Update: A Multicenter, Double-Blind, Randomized, Placebo-Controlled, 12-Week, Dose-Range-Finding Trial of YKP10811 Capsules Administered Once Daily to Subjects With Chronic Idiopathic Constipation [Phase 2]
A multicenter, double-blind, randomized, placebo-controlled Phase 2 dose-range-finding trial of YKP10811 for chronic idiopathic constipation…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2014-12-11FDA Approved: LINZESS — Supplemental Application (Allergan, Inc.)
The FDA approved a supplemental application for Linzess (linaclotide) from Allergan, expanding its labeling.
-
FDA approval · 2014-07-09FDA Approved: LINZESS — Supplemental Application (Allergan, Inc.)
FDA approved a supplemental application for Linzess (linaclotide) filed by Allergan, Inc.
-
CLINICAL_TRIALS trial_result · 2014-04-03Clinical Trial Update: Evaluation of Clinical Equivalence Between Two Lubiprostone Products in the Treatment of Chronic Idiopathic Constipation [Phase 3]
A Phase 3 trial completed to evaluate clinical equivalence between two lubiprostone products for chronic idiopathic constipation.
-
CLINICAL_TRIALS trial_result · 2013-10-30Clinical Trial Update: A Exploratory Study of KWA-0711 in Patients With Chronic Idiopathic Constipation (CIC) [Phase 2]
This Clinical Trial Update reports the completion of a Phase 2 exploratory study of KWA-0711 for chronic idiopathic constipation.
-
FDA approval · 2013-08-19FDA Approved: LUBIPROSTONE — Supplemental Application (Dr. Reddy's Laboratories Inc.)
FDA approved a supplemental application for Lubiprostone from Dr. Reddy's Laboratories Inc.
-
FDA approval · 2013-08-08FDA Approved: LINZESS — Supplemental Application (Allergan, Inc.)
The FDA approved a supplemental application for Linzess (linaclotide) from Allergan, Inc., resulting in an updated labeling or indication fo…
-
FDA approval · 2013-04-19FDA Approved: LUBIPROSTONE — Supplemental Application (Dr. Reddy's Laboratories Inc.)
FDA approved a supplemental application for Lubiprostone filed by Dr. Reddy's Laboratories Inc.
-
FDA approval · 2012-11-26FDA Approved: LUBIPROSTONE — Supplemental Application (Dr. Reddy's Laboratories Inc.)
FDA approved a supplemental application for Lubiprostone submitted by Dr. Reddy's Laboratories.
-
CLINICAL_TRIALS withdrawal · 2012-09-13Clinical Trial Update: Domperidone for Relief of Gastrointestinal Disorders [NA]
The clinical trial evaluating domperidone for relief of various gastrointestinal disorders has been terminated.
-
FDA approval · 2012-08-30FDA Approved: LINZESS — Original Application (Allergan, Inc.)
The FDA approved Linzess (linaclotide) through its Original Application by Allergan, establishing its use for adults with irritable bowel sy…
-
CLINICAL_TRIALS trial_result · 2012-07-12Clinical Trial Update: Evaluation of Clinical Equivalence Between Two Lubiprostone Products [Phase 3]
Phase 3 trial evaluating clinical equivalence between two lubiprostone products (brand vs generic) in adults with chronic idiopathic constip…
-
CLINICAL_TRIALS withdrawal · 2010-11-18Clinical Trial Update: A Treatment Investigational New Drug (tIND) Program of Tegaserod in Women With Irritable Bowel Syndrome With Constipation or With Chronic Idiopathic Constipation
Clinical trial update indicating the tegaserod tIND program in women with irritable bowel syndrome with constipation or chronic idiopathic c…
-
CLINICAL_TRIALS trial_result · 2008-05-29Clinical Trial Update: Trial to Evaluate the Efficacy and Safety of R093877 in Patients With Chronic Idiopathic Constipation [Phase 2]
Phase 2 trial evaluating the efficacy and safety of R093877 in patients with chronic idiopathic constipation has completed.
-
CLINICAL_TRIALS trial_result · 2008-05-29Clinical Trial Update: Effect of Prucalopride in Patients With Severe Chronic Idiopathic Constipation [Phase 2]
Phase 2 trial evaluating prucalopride for severe chronic idiopathic constipation has completed.
-
CLINICAL_TRIALS trial_result · 2008-05-29Clinical Trial Update: Prucalopride in Patients With Chronic Idiopathic Constipation [Phase 2]
A Phase 2 trial evaluating prucalopride for chronic idiopathic constipation has completed.
-
FDA approval · 2008-04-29FDA Approved: LUBIPROSTONE — Supplemental Application (Dr. Reddy's Laboratories Inc.)
The FDA approved a supplemental application for Lubiprostone filed by Dr. Reddy's Laboratories Inc., indicating an update to the product lab…